Vol 9: Development and Validation of a Clinical Scoring System for Predicting Risk of HCC in Asymptomatic Individuals Seropositive for Anti-HCV Antibodies.Reportar como inadecuado



 Vol 9: Development and Validation of a Clinical Scoring System for Predicting Risk of HCC in Asymptomatic Individuals Seropositive for Anti-HCV Antibodies.


Vol 9: Development and Validation of a Clinical Scoring System for Predicting Risk of HCC in Asymptomatic Individuals Seropositive for Anti-HCV Antibodies. - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.

Descargar gratis o leer online en formato PDF el libro: Vol 9: Development and Validation of a Clinical Scoring System for Predicting Risk of HCC in Asymptomatic Individuals Seropositive for Anti-HCV Antibodies.
This article is from PLoS ONE, volume 9.AbstractBackground: The development of a risk assessment tool for long-term hepatocellular carcinoma risk would be helpful in identifying high-risk patients and providing information of clinical consultation. Methods: The model derivation and validation cohorts consisted of 975 and 572 anti-HCV seropositives,

Autor: Lee, Mei-Hsuan; Lu, Sheng-Nan; Yuan, Yong; Yang, Hwai-I; Jen, Chin-Lan; You, San-Lin; Wang, Li-Yu; L'Italien, Gilbert; Chen, Chien-Jen

Fuente: https://archive.org/







Documentos relacionados